河北医科大学学报
河北醫科大學學報
하북의과대학학보
JOURNAL OF HEBEI MEDICAL UNIVERSITY
2014年
9期
1040-1043
,共4页
冯锐%郑颖%张俊贞%王明霞%刘江%尉晓然
馮銳%鄭穎%張俊貞%王明霞%劉江%尉曉然
풍예%정영%장준정%왕명하%류강%위효연
瑞芬太尼%血浆%色变法%高压液相
瑞芬太尼%血漿%色變法%高壓液相
서분태니%혈장%색변법%고압액상
remifentanil%plasma%chromatography,high pressure liquid
目的:建立血浆中瑞芬太尼高效液相色谱测定方法,为临床合理用药提供依据。方法血浆样品用1-氯丁烷进行萃取,上清液提取至0.01mol/L盐酸溶液中。分析柱为spherisorb-CN,流动相为0.02mol/L的NaH2 PO4水溶液-乙腈(70:30),内含三乙胺0.01%,流速1.5mL/min,柱温为室温,紫外检测波长为210nm,进样量为200μL。选择择期行胸科手术患者8例,靶控输注瑞芬太尼浓度( Cp)6μg/L复合异丙酚2.5mg/kg,分别在瑞芬太尼靶控输注前及靶控输注后5、10、20、30、60、90min时抽取桡动脉血,用高效液相色谱法测定瑞芬太尼血药浓度(Cm)。结果人血浆中瑞芬太尼检测浓度在2.5~300μg/L范围内线性关系良好(r=0.9991)。日内日间精密度均在10%以内,提取回收率大于78.57%,方法回收率在96.03%~104.67%。在靶控输注5~20min时,瑞芬太尼测定浓度低于靶控输注浓度( p<0.05),30~90min两者差异无统计学意义( p>0.05)。结论该方法操作简便,分离度好,其专属性、准确度、精密度、线性范围及稳定性均适合实际样品的检测。
目的:建立血漿中瑞芬太尼高效液相色譜測定方法,為臨床閤理用藥提供依據。方法血漿樣品用1-氯丁烷進行萃取,上清液提取至0.01mol/L鹽痠溶液中。分析柱為spherisorb-CN,流動相為0.02mol/L的NaH2 PO4水溶液-乙腈(70:30),內含三乙胺0.01%,流速1.5mL/min,柱溫為室溫,紫外檢測波長為210nm,進樣量為200μL。選擇擇期行胸科手術患者8例,靶控輸註瑞芬太尼濃度( Cp)6μg/L複閤異丙酚2.5mg/kg,分彆在瑞芬太尼靶控輸註前及靶控輸註後5、10、20、30、60、90min時抽取橈動脈血,用高效液相色譜法測定瑞芬太尼血藥濃度(Cm)。結果人血漿中瑞芬太尼檢測濃度在2.5~300μg/L範圍內線性關繫良好(r=0.9991)。日內日間精密度均在10%以內,提取迴收率大于78.57%,方法迴收率在96.03%~104.67%。在靶控輸註5~20min時,瑞芬太尼測定濃度低于靶控輸註濃度( p<0.05),30~90min兩者差異無統計學意義( p>0.05)。結論該方法操作簡便,分離度好,其專屬性、準確度、精密度、線性範圍及穩定性均適閤實際樣品的檢測。
목적:건립혈장중서분태니고효액상색보측정방법,위림상합리용약제공의거。방법혈장양품용1-록정완진행췌취,상청액제취지0.01mol/L염산용액중。분석주위spherisorb-CN,류동상위0.02mol/L적NaH2 PO4수용액-을정(70:30),내함삼을알0.01%,류속1.5mL/min,주온위실온,자외검측파장위210nm,진양량위200μL。선택택기행흉과수술환자8례,파공수주서분태니농도( Cp)6μg/L복합이병분2.5mg/kg,분별재서분태니파공수주전급파공수주후5、10、20、30、60、90min시추취뇨동맥혈,용고효액상색보법측정서분태니혈약농도(Cm)。결과인혈장중서분태니검측농도재2.5~300μg/L범위내선성관계량호(r=0.9991)。일내일간정밀도균재10%이내,제취회수솔대우78.57%,방법회수솔재96.03%~104.67%。재파공수주5~20min시,서분태니측정농도저우파공수주농도( p<0.05),30~90min량자차이무통계학의의( p>0.05)。결론해방법조작간편,분리도호,기전속성、준학도、정밀도、선성범위급은정성균괄합실제양품적검측。
OcjectiVe High performance liquid chromarography ( HPLC ) method was established for determination of remifentanil in plasma. The study will provide academic foundation for the development and clinical use of remifentanil. Methods The samples eXtracted with 1-chlorobutane and supernatant was back eXtracted into 0. 01mol/L HCl again. The separation was performed on a spherisorb-CN column with a mobile phase of 0. 02mol/L-1NaH2 PO4-acetonitrile( 70: 30 ) including 0. 01%triethylamine at a flow rate of 1. 5mL/min. The column temperature was room temperature,the detection-wavelength was 210nm and 200μL of solution was injected into HPLC. Eight patients undergoing thoracic surgery were assigned to receive remifentanil target controlled infusion( TCI )( 6μg/L ) and propofol intravenous injection(2. 5mg/kg). Arterial blood samples were taken before and after TCI remifentanil 5, 10,20,30,60,90 min for measuring of blood concentration of remifentanil by HPLC. Results A linearity was obtained from 2 . 5μg/L to 300μg/L of remifentanil in plasma with a good correlation( r=0 . 999 1 ). The between-day and within-day RSD% were less than 10%. The eXtraction recoveries were more than 78 . 57%,and the method recoveries were between 96 . 03% and 104 . 67%. The determination of the concentration was lower than target plasma concentration at TCI 5 min to 20 min( p<0 . 05 )and there was no significant difference from 30 min to 90 min( p >0 . 05 ). Conclusion This HPLC method is simple,sensitive and accurate,and it is suitable for routine determination of remifentanil levels in human plasma.